News
Tramway Venture Partners
Tramway Ventures lands state boost for new $40M fund
By Jacob Maranda – New Mexico Inno Reporter September 19, 2023, 05:12pm MDT There could soon be a lot more venture capital flowing into New Mexico companies thanks to…
Tramway Ventures Welcomes Chris Japp as Managing Partner
[Albuquerque, August 21, 2023] – Tramway Ventures, New Mexico’s leading life sciences and healthcare venture capital firm, proudly announces the appointment of Chris Japp as Managing Partner to the firm….
Albuquerque’s Tramway Venture Partners raising investment fund for tech companies
By – Collin Krabble, Technology reporter, Albuquerque Business First Nov 9, 2020, 4:25pm EST Albuquerque venture capital firm Tramway Venture Partners is raising a multimillion fund to invest in tech…
Armonica Technologies
NM startup on cusp of DNA sequencing breakthrough
By Kevin Robinson-Avila / Journal Staff Writer Published: Sunday, October 2nd, 2022 at 9:02PM Updated: Monday, October 3rd, 2022 at 12:02AM Technology to rapidly read long strands of DNA…
Armonica Technologies closes B Round Financing
ALBUQUERQUE, N.M., Oct. 18, 2021 /PRNewswire/ — Armonica Technologies, Inc., a biotechnology company developing a high throughput, direct long-read DNA sequencing technology, announced that it has raised $2M in new funding. The financing included…
Armonica Technologies Awarded NIH Grant
ALBUQUERQUE, N.M., March 29, 2021 /PRNewswire/ — Armonica Technologies, Inc., a biotechnology company developing a novel DNA sequencing system based on nano-structure devices, announced that the company has been awarded an SBIR grant…
BennuBio
Spherical analysis
BY KEVIN ROBINSON-AVILA / JOURNAL STAFF WRITER PUBLISHED: FRIDAY, JULY 17TH, 2020 Medical device startup BennuBio Inc. won a $1 million National Institutes of Health grant to add rapid analysis capability…
BennuBio Inc. Receives $1 Million Grant For Novel Biological Screening Technology Development
BennuBio was awarded an NIH (National Institute of Health) SBIR (Small Business Innovation Research) grant that will advance the Company’s development of a novel analytic tool for 3D tissue models….
Flow Cytometry Startup BennuBio Secures $5M in Series B Funding Round
NEW YORK – Flow cytometry startup BennuBio has closed on $5 million of a $7 million Series B financing round, which it plans to use to expand commercial efforts, accelerate…
- « Previous
- 1
- 2
Circular Genomics
Circular Genomics Announces Two Significant Steps Forward in Linking CircRNA to the Detection, Therapy Selection and Monitoring of Depressive Conditions
Albuquerque, NM, July 11, 2023 (GLOBE NEWSWIRE) — Circular Genomics, the global leader in the use of circular RNA (circRNA) biomarkers for precision psychiatry, today announced the results of a…
Precision Medicine in Mental Health Company, Circular Genomics, Appoints, Dr. Paul Sargeant as Chief Executive Officer
ALBUQUERQUE, N.M., April 27, 2023 /PRNewswire/ — Circular Genomics, the leading company in developing circular RNA-based precision medicine tools, data and diagnostics for neurology and psychiatry, has appointed Paul Sargeant,…
Circular Genomics uses RNA to stop depression meds being a guessing game
Devin Coldewey@techcrunch / 12:40 PM MDT•October 18, 2022 Image Credits: Bryce Durbin / TechCrunch For many people who live with depression, medication is an important part of managing the…
WaveDyn Vision
WaveFront Dynamics Inc. Launches WaveDȳn® Vision Analyzer
ALBUQUERQUE, N.M.–(BUSINESS WIRE)–WaveFront Dynamics Inc., an ophthalmic medical device company, announced today the commercial launch of its dynamic aberrometry measurement system, the WaveDyn Vision Analyzer. The WaveDyn Vision Analyzer (pronounced…
WaveFront Dynamics Inc. Initiates $3mm Series A Round to Fund Continued Development of Dynamic Wavefront Measurement System for Vision Correction
ALBUQUERQUE, N.M.–(BUSINESS WIRE)–WaveFront Dynamics Inc. (WaveDyn™), an early stage ophthalmic medical device company, today announced the first close of a $3 million Series A financing round. The round was led by…
WaveFront Dynamics Names Jeff Kolberg as New Chief Commercial Officer
ALBUQUERQUE, N.M.–(BUSINESS WIRE)–WaveFront Dynamics Inc. (WaveDyn™), an early stage ophthalmic medical device company, today announced that Jeff Kolberg has been appointed as the company’s Chief Commercial Officer (CCO). Mr. Kolberg…
Vitazi.ai
Vitazi.ai Creates a Platform to Deliver Artificial Intelligence to Improve Physician Efficiency and Diagnostics Accuracy
Vitazi.ai is reimagining image-based diagnostics so providers can gain higher quality, real time & trustable health insights. October 8, 2021 Albuquerque, New Mexico — Today Tramway Venture Partners…